Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide BP Effect in T2D
NCT01499108Phase 4Completed
- Start
- Aug 2012
- Primary completion
- Jul 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM). Started Aug 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01499108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499108.